Tenderwize
Wróć do wyszukiwania

Open house pharmaceutical discount agreements for active substance Biperiden, ATC N04AA02

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 217 days left·Open·Supplies
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Biperiden, ATC N04AA02

45/100

Ocena szansy

Needs reviewLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

45 / 100

Złożoność

30 / 100

Czynniki ryzyka

The buyer reserves the right to replace open-house agreements with exclusive discount contracts, which would automatica...

No estimated volume or value; discount rates are not specified but must be agreed upon. The actual profitability depend...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of authorized and marketable pharmaceutical products containing Biperiden (ATC N04AA02).
  • Agreement to offer discount on the drug's price as per SGB V §§130a(8)/130c(1).
Pokaż pełne podsumowanie

This is an open-house model for non-exclusive pharmaceutical discount agreements on the active substance Biperiden (ATC N04AA02) with AOK Rheinland-Pfalz/Saarland. The contract is not a public procurement under EU directives but published voluntarily for transparency. The procedure allows any interested pharmaceutical company to enter into a standard agreement at any time during a 24-month window (June 2025 – May 2027), with uniform conditions. No estimated value is provided. The buyer reserves the right to replace these agreements with exclusive ones through separate tenders, which would automatically terminate open-house contracts.

Ryzyka

The buyer reserves the right to replace open-house agreements with exclusive discount contracts, which would automatica...

No estimated volume or value; discount rates are not specified but must be agreed upon. The actual profitability depend...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Products must be authorized and marketable in Germany (verified via Lauer-Taxe or AMIce database).

Administrative

  • Submission of signed contract documents and supporting evidence of drug authorization/marketability.
  • No electronic submission allowed; documents must be submitted in original.

Zamawiający

Lokalizacja

Eisenberg, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE271900642

Działalność

Health

Części (1)

LOT-0001

Open house pharmaceutical discount agreements for active substance Biperiden, ATC N04AA02

Non-exclusive discount agreements for Biperiden products. All interested pharmaceutical companies can join under uniform terms. Maximum contract duration 24 months. First possible start date: 01.06.2025. Contracts can be terminated by the buyer early if exclusive agreements are concluded.

SuppliesEU fundedElectronic submission

Lokalizacja

Eisenberg, Germany

Czas trwania

May 2025 - May 2027

Kategoria

Pharmaceutical products

Szczegóły zamówienia

Data publikacji
10 Apr 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
235451-2025

Dokumenty (1)

Podobne przetargi